Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR1405-01 injection for moderate to severe postoperative orthopedic pain
ChiCTR2400084045Phase 2Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of HR1405-01 in postoperative pain (3 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Total morphine consumption within 24 hours. Started May 2024; status: recruiting.
02
Drugs
HR1405-01
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400084045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084045.